1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6969A74FC9D12B52800258B890018B3B4
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/building-more-effective-medical-affairs-product-launch-teams-hematology-segment
18
19
2018.97.14.85
21
22
23best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Launch Optimization

Building More Effective Medical Affairs Product Launch Teams: Hematology Segment

ID: POP-387


Features:

12 Info Graphics

32 Data Graphics

650+ Metrics

18 Narratives


Pages: 56


Published: 2024


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
As hematology treatments proliferate, the strategic involvement of Medical Affairs is crucial for successful product launches. Organizations are now integrating medical expertise earlier in the product lifecycle, leading to more cohesive and agile launch strategies. This approach not only enhances stakeholder engagement but also helps organizations preempt challenges and streamline market entry.

Best Practices, LLC conducted this benchmarking research to explore the evolving role of Medical Affairs in hematology product launches. The report examines shifting roles and responsibilities, cross-functional alignment, performance metrics, resourcing, activity effectiveness, launch timelines, and the deployment of digital tools within the hematology therapeutic area. The report also identifies critical success factors and challenges that are vital for achieving launch excellence in this field.

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Academic; Research; Biotech; Chemical; Consulting; Consumer Products; Health Care; Medical Device


Companies Profiled:
Apellis Pharmaceuticals; ASC Therapeutics; AstraZeneca; Duke University and Health System; Eurofarma; Genentech; Helsinn; Kyowa Kirin; MEDiSTRAVA; Novartis; Pixacore; Sandoz; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies

Study Snapshot

Best Practices, LLC engaged 17 Medical leaders from 14 leading life sciences companies in this benchmarking research study. Medical Directors and upper management executives represent nearly four-fifths of the leaders who shared data and insights on Medical launch activities in this study.


Key topics covered in this report include:

  • Medical Leadership Roles and Launch Activity Effectiveness in Hematology
  • Ensuring Cross-functional Alignment and Collaboration in Hematology Launches
  • Medical Launch Evolution in Hematology Segment
  • Hematology Launch Activities Timeline, Performance Tracking, and Resourcing
  • Critical Success Factors and Major Pitfalls for Medical Affairs During Hematology Launches
  • Digital Launch Implementation and Impact in Hematology
  • Launch Tool Deployment for Hematology Products

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • Medical Leadership Roles: Internal disease training and medical strategy are launch priorities consistently led by Medical Affairs.
  • Launch Challenges: Poor cross-functional alignment and delayed involvement in launch activities are common pitfalls for Medical Affairs during launch.
Table of Contents

Sr. No.
Topic
Slide No.
I.
Executive SummaryPg. 4
II.
Section I: Launch Excellence and Medical’s Role & Activity EffectivenessPg. 6-12
III.
Section II: Ensuring Cross-functional Alignment and CollaborationPg. 13-15
IV.
Section III: Adopting to Ongoing Changes in Medical LandscapePg. 16-20
V.
Section IV: Launch Timeline, Preparedness Metrics, and ResourcingPg. 21-26
VI.
Section V: Critical Success Factors and Major PitfallsPg. 27-32
VII.
Section VI: Digital Influence on Launch Processes and Launch Tool DeploymentPg. 33-41
VIII.
Section VII: Participant DemographicsPg. 42-43
IX.
Section VIII: Detailed Benchmark Study DataPg. 44-55
X.
Section IX: About Best Practices, LLCPg. 56

    List of Charts & Exhibits

    I. Launch Excellence and Medical’s Role & Activity Effectiveness

    • Medical launch excellence framework
    • Medical Affairs’ role in hematology launches
    • Medical leadership roles in hematology launches
    • Medical Affairs’ effectiveness in hematology launch activities
    • Most effective launch activities for Medical Affairs in hematology
    • Improvement opportunities for Medical Affairs around hematology launch activities

    II. Ensuring Cross-functional Alignment and Collaboration

    • Medical Affairs’ work with internal colleagues to ensure successful hematology launches
    • Role of Medical Affairs group in cross-functional hematology launch teams

    III. Adopting to Ongoing Changes in Medical Landscape

    • Change fronts for Medical launch evolution
    • Medical Affairs’ launch evolution around digital data dissemination and communication
    • Medical Affairs’ launch evolution around medical education
    • Medical Affairs’ launch evolution around organizational support

    IV. Launch Timeline, Preparedness Metrics and Resourcing

    • Medical Affairs’ hematology launch activities timeline
    • Total annual Medical Affairs launch investment in U.S. dollars and number of FTEs for hematology products during each of the years in launch phase
    • Launch dashboard and information used with the dashboard for hematology
    • Percentage of total Medical Affairs launch investment allocated to each of the listed Medical Affairs activities in hematology
    • Percentage of total Medical Affairs launch FTEs allocated to each of the listed Medical Affairs activities in hematology

    V. Critical Success Factors and Major Pitfalls

    • Critical success factors for Medical Affairs in hematology launches
    • Areas where advanced team planning is key for hematology launches
    • Six critical areas for successful Medical Affairs launch readiness in hematology
    • Major pitfalls for Medical Affairs during hematology launches
    • Six major challenge areas for Medical Affairs during hematology launches

    VI. Digital Influence on Launch Processes and Launch Tool Deployment

    • Post-pandemic digital technology utilization in Medical Affairs during hematology product launches
    • Impact of digital technologies on current and future hematology launch processes
    • Digital launch tool deployment and impact
    • Impact of top three digital activities that Medical leads in hematology
    • Impact of digital activities and programs used to support a successful hematology product launch
    • Top digital tools that can bring success to Medical Affairs product launch activities
    • Fast-growing digital tools that are impacting Medicals’ launch strategy
    • Example of a valuable digital tool that supports launch activities

    VII. Participant Demographics

    • Geographic responsibility of benchmark partners

    VIII. Detailed Benchmark Study Data

    • Role served by Medical Affairs in hematology product launches
    • Medical Affairs’ launch role effectiveness in hematology
    • Role served by Medical Affairs in planning, research, and education activities in hematology segment
    • Role served by Medical Affairs in data dissemination and organizational support activities in hematology segment
    • Role served by Medical Affairs in research activities in hematology segment
    • Role served by Medical Affairs in education and data dissemination support activities in hematology segment
    • Role served by Medical Affairs in organizational support activities in hematology segment
    • Medical Affairs launch activity involvement timeline - Evidence generation and field-based medical activities in hematology
    • Medical Affairs launch activity involvement timeline - Medical information and medical regulatory activities in hematology
    • Medical Affairs launch activity involvement timeline - HEOR activities and medical / scientific communications in hematology
    • Medical Affairs launch activity involvement timeline - Independent medical education and external engagement activities in hematology